<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-US">
	<id>https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3AInsurance_acquisition_cash_flows</id>
	<title>Definition:Insurance acquisition cash flows - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3AInsurance_acquisition_cash_flows"/>
	<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Insurance_acquisition_cash_flows&amp;action=history"/>
	<updated>2026-05-16T10:02:53Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://www.insurerbrain.com/w/index.php?title=Definition:Insurance_acquisition_cash_flows&amp;diff=22758&amp;oldid=prev</id>
		<title>PlumBot: Bot: Creating definition</title>
		<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Insurance_acquisition_cash_flows&amp;diff=22758&amp;oldid=prev"/>
		<updated>2026-03-31T17:39:06Z</updated>

		<summary type="html">&lt;p&gt;Bot: Creating definition&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;💰 &amp;#039;&amp;#039;&amp;#039;Insurance acquisition cash flows&amp;#039;&amp;#039;&amp;#039; are the cash flows arising from the costs of selling, [[Definition:Underwriting|underwriting]], and initiating a group of [[Definition:Insurance contracts|insurance contracts]], and they occupy a specific and important role under [[Definition:IFRS 17|IFRS 17]], the international standard for insurance contract accounting. These cash flows include agent and broker [[Definition:Commission|commissions]], costs of medical examinations for [[Definition:Life insurance|life insurance]] applicants, underwriting salaries directly attributable to the portfolio, and other incremental costs that would not have been incurred had the contracts not been issued. IFRS 17 introduced a more rigorous treatment of these costs than its predecessor [[Definition:IFRS 4|IFRS 4]], requiring them to be allocated to groups of contracts and recognized as part of the [[Definition:Fulfilment cash flows|fulfilment cash flows]] used to measure the insurance contract liability.&lt;br /&gt;
&lt;br /&gt;
🔧 Under IFRS 17&amp;#039;s [[Definition:General measurement model|general measurement model]] (also known as the building block approach), insurance acquisition cash flows are included in the measurement of the [[Definition:Contractual service margin|contractual service margin]] (CSM) at initial recognition. Rather than being expensed immediately when incurred — as was common practice in some jurisdictions under previous standards — these cash flows reduce the CSM of the group of contracts to which they relate, meaning they are effectively amortized over the [[Definition:Coverage period|coverage period]] as the insurer earns revenue. If the acquisition cash flows relate to contracts that have not yet been recognized (i.e., expected future renewals within the same group boundary), IFRS 17 requires an asset for insurance acquisition cash flows to be recorded on the balance sheet. This asset is subject to its own recoverability assessment: at each reporting date, the insurer must test whether the asset is recoverable from the expected future cash inflows of the related contracts, recognizing any shortfall immediately in [[Definition:Profit or loss|profit or loss]].&lt;br /&gt;
&lt;br /&gt;
📌 The treatment of insurance acquisition cash flows under IFRS 17 has significant practical implications for how insurers report profitability, particularly in lines of business with high upfront acquisition costs such as [[Definition:Broker|broker]]-intermediated commercial insurance and individual life policies. Under previous regimes, the immediate expensing of acquisition costs could create a so-called &amp;quot;new business strain&amp;quot; — a drag on earnings in the year of policy inception. IFRS 17&amp;#039;s deferral mechanism smooths this effect but introduces complexity in allocation, grouping, and recoverability testing. The standard&amp;#039;s requirements in this area were amended in 2020 following industry feedback, particularly to clarify the allocation of acquisition cash flows across renewal periods. For insurers transitioning from [[Definition:US GAAP|US GAAP]] — which has its own [[Definition:Deferred acquisition cost|deferred acquisition cost]] (DAC) asset concept under [[Definition:ASC 944|ASC 944]] — the IFRS 17 approach is conceptually related but differs materially in mechanics and measurement, requiring careful reconciliation for groups reporting under both frameworks.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Related concepts:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
{{Div col|colwidth=20em}}&lt;br /&gt;
* [[Definition:IFRS 17]]&lt;br /&gt;
* [[Definition:Contractual service margin]]&lt;br /&gt;
* [[Definition:Fulfilment cash flows]]&lt;br /&gt;
* [[Definition:Deferred acquisition cost]]&lt;br /&gt;
* [[Definition:General measurement model]]&lt;br /&gt;
* [[Definition:Commission]]&lt;br /&gt;
{{Div col end}}&lt;/div&gt;</summary>
		<author><name>PlumBot</name></author>
	</entry>
</feed>